company background image
A144510 logo

GC Cell KOSDAQ:A144510 Stock Report

Last Price

₩40.30k

Market Cap

₩605.4b

7D

4.4%

1Y

-9.4%

Updated

28 Feb, 2024

Data

Company Financials

GC Cell Corporation

KOSDAQ:A144510 Stock Report

Market Cap: ₩605.4b

A144510 Stock Overview

GC Cell Corporation develops cell therapy products.

A144510 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Rewards

Risk Analysis

No risks detected for A144510 from our risk checks.

GC Cell Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for GC Cell
Historical stock prices
Current Share Price₩40,300.00
52 Week High₩49,250.00
52 Week Low₩28,450.00
Beta0.99
1 Month Change-0.98%
3 Month Change27.13%
1 Year Change-9.44%
3 Year Change-57.80%
5 Year Change-19.88%
Change since IPO-16.22%

Recent News & Updates

Recent updates

We Think Green Cross Lab Cell's (KOSDAQ:144510) Robust Earnings Are Conservative

Mar 19
We Think Green Cross Lab Cell's (KOSDAQ:144510) Robust Earnings Are Conservative

We Think Green Cross Lab Cell (KOSDAQ:144510) Can Stay On Top Of Its Debt

Feb 22
We Think Green Cross Lab Cell (KOSDAQ:144510) Can Stay On Top Of Its Debt

Can Green Cross Lab Cell Corporation (KOSDAQ:144510) Improve Its Returns?

Jan 18
Can Green Cross Lab Cell Corporation (KOSDAQ:144510) Improve Its Returns?

Can You Imagine How Jubilant Green Cross Lab Cell's (KOSDAQ:144510) Shareholders Feel About Its 139% Share Price Gain?

Dec 14
Can You Imagine How Jubilant Green Cross Lab Cell's (KOSDAQ:144510) Shareholders Feel About Its 139% Share Price Gain?

Shareholder Returns

A144510KR BiotechsKR Market
7D4.4%7.7%-1.2%
1Y-9.4%15.9%8.5%

Return vs Industry: A144510 underperformed the KR Biotechs industry which returned 15.9% over the past year.

Return vs Market: A144510 underperformed the KR Market which returned 8.5% over the past year.

Price Volatility

Is A144510's price volatile compared to industry and market?
A144510 volatility
A144510 Average Weekly Movement7.3%
Biotechs Industry Average Movement7.7%
Market Average Movement5.1%
10% most volatile stocks in KR Market11.7%
10% least volatile stocks in KR Market2.4%

Stable Share Price: A144510 has not had significant price volatility in the past 3 months.

Volatility Over Time: A144510's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2011769James Parkhttps://www.gccell.com

GC Cell Corporation develops cell therapy products. It also provides cell banking, sample inspection, clinical trial, and bio logistics services. The company was formerly known as Green Cross Lab Cell Corporation and changed its name to GC Cell Corporation in November 2021.

GC Cell Corporation Fundamentals Summary

How do GC Cell's earnings and revenue compare to its market cap?
A144510 fundamental statistics
Market cap₩605.41b
Earnings (TTM)-₩10.81b
Revenue (TTM)₩182.08b

3.3x

P/S Ratio

-56.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A144510 income statement (TTM)
Revenue₩182.08b
Cost of Revenue₩133.90b
Gross Profit₩48.18b
Other Expenses₩58.99b
Earnings-₩10.81b

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-719.76
Gross Margin26.46%
Net Profit Margin-5.94%
Debt/Equity Ratio7.3%

How did A144510 perform over the long term?

See historical performance and comparison

Dividends

0.2%

Current Dividend Yield

-49%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.